The Archive · 3 posts
Explore the future of technology with Capai PLC! 💡 CPAI is setting trends in innovation & growth on the LSE. Join the tech revolution today! 🚀
capAI has licensed the beta-stage Ageotype health platform worldwide and secured a £2 million option to acquire its intellectual property.
July 23, 2026
Showing 2 of 3 posts
capAI secures exclusive licence for Game42 AI platform with zero upfront cost and option to acquire IP for £2M. Strategic gaming play with clear upside.
JoshuaSeptember 2, 2025
CapAI's zero-cost Author42 licence deal: 12-month exclusive rights with £2m acquisition option. Cleverly structured AI platform play.
JoshuaJuly 25, 2025